Heart atlas
Mapping the human heart for the human cell atlas
An international team of researchers are seeking to explore the heart at a depth that was previously impossible.
Mapping the human heart for the human cell atlas
An international team of researchers are seeking to explore the heart at a depth that was previously impossible.
Heart attack patients with diabetes may benefit from cholesterol-lowering drug
Injections of a cholesterol-cutting drug could reduce the risk of heart attack or stroke in patients with diabetes who have had a recent heart attack.
Heart disease patients given chance to further research with the Heart Hive
New ways of connecting patients and researchers are giving new hope of finding cures for rare heart conditions.
Long-term health effects of armed conflict could last years after fighting stops
Living in a warzone is linked with an increased risk of heart attack and stroke among civilians, even years after the conflict ends.
British Heart Foundation renews Imperial’s Research Excellence Award
The renewed British Heart Foundation Centre of Research Excellence at Imperial will be funded until 2024.
New cholesterol-lowering drug could help patients unable to take statins
A new class of oral cholesterol-lowering drug could help patients unable to take statins due to side effects.
Professor Wood recognised as Emeritus Professor of Cardiology
Professor David Wood has been awarded the title Emeritus Professor of Cardiology following his retirement from the National Heart and Lung Institute.
Aspirin cuts heart attack risk but increases chance of dangerous bleeding
Regular aspirin should not be recommended for preventing heart attack and stroke in people without cardiovascular disease.
New blood tests for TB could accelerate diagnosis and save the NHS money
Rapid blood tests used by the NHS are unable to rule out tuberculosis (TB) and should be replaced with a new, more accurate test, a study has found.
Imperial and Bayer to accelerate drug discovery for heart conditions using AI
A new industrial partnership will use artificial intelligence (AI) to speed up drug discovery.